Johnson & Johnson CEO on vaccine authorization
Johnson and Johnson CEO Alex Gorsky joins "CBS This Morning" to discuss FDA emergency use authorization of his company's one-shot coronavirus vaccine, a first.
COVID-19
Biden criticized for decision on Saudi prince
President Biden is facing growing criticism for failing to sanction Saudi Crown Prince Mohammed bin Salman for the killing of journalist Jamal Khashoggi. This comes as sources tell CBS News that the State Department will highlight a "reset and recalibration" of the U.S. relationship with Saudi Arabia. CBS News chief White House correspondent Nancy Cordes joins CBSN with details on that, plus Mr. Biden's upcoming meeting with the president of Mexico and the latest on his COVID relief plan.
Johnson & Johnson ships COVID-19 vaccine
Johnson & Johnson has begun shipping its single-dose COVID-19 vaccine, the third jab to become available in the United States as the country races to get Americans inoculated. Dr. Rick Nettles, the vice president of medical affairs for Janssen Infectious Diseases and Vaccines at Johnson & Johnson, joins CBSN to answer questions about the company's vaccine.
Johnson & Johnson begins shipping vaccine
The new single-dose vaccine began shipping out Monday morning after the FDA issued emergency use authorization for the shot. It is the third COVID-19 vaccine to become available in the United States. CBS News' Debra Alfarone joins CBSN AM to discuss.
Cuomo's conduct in spotlight amid allegations
New York Governor Andrew Cuomo, who saw soaring popularity during the coronavirus pandemic, is facing calls to resign after two former aides accused him of sexual harassment. According to the New York Times, a second former aide claims the Democrat repeatedly asked her questions about her sex life while she worked for him last year. CBS News correspondent Jericka Duncan reports on the latest, and Alyssa Katz, deputy editor for The City, joined CBSN to discuss Cuomo's past behavior.
Johnson & Johnson CEO touts "ease" of single-shot vaccine distribution
Four million doses are being shipped out Monday of the newly-approved coronavirus vaccination, with 100 million promised by the end of June.
What to expect from Johnson & Johnson vaccine
The new Johnson & Johnson vaccine could roll out as early as this week. CBS News medical contributor Dr. David Agus has more on what to expect.
Kentucky governor explains decision to vaccinate teachers firs
Democratic Governor Andy Beshear explains his state's decision to move educators to the front of the line for vaccinations.
U.S. hits grim COVID milestone amid new hope of third vaccine
CBS News senior national correspondent Mark Strassmann reports on the latest developments in vaccine distribution as the U.S. continues its battle against COVID-19.
Is the one-shot method better than the two-shot method?
Which vaccine is the most effective against the coronavirus? The Moderna and Pfizer vaccines require two shots to be fully vaccinated. However, the new Johnson and Johnson vaccine uses a one-shot method and is easier to store. CBS News researcher Max Bayer joins CBSN's Land Zak to discuss the difference between the vaccines, their efficacy against variants, and if pregnant women should be vaccinated.
Frontline workers' mental health struggles
Although there is optimism among frontline healthcare workers as coronavirus infections decline, many of them report experiencing mental health problems. New studies show that nearly half may have mental health issues including anxiety, depression and PTSD. Lilia Luciano reports.
House passes Biden's COVID-19 relief bill
This Saturday, the House of Representatives passed President Biden's new $1.9 trillion dollar coronavirus economic relief bill, although without bipartisan support. The bill now goes to the Senate for approval. Christina Ruffini has more.
FDA approves one-shot vaccine
On Saturday, the FDA approved the one-shot Johnson & Johnson COVID-19 vaccine. The race to vaccinate is picking up as new variants have been identified. Danya Bacchus reports.
House Dem calls $15 minimum wage a priority
President Biden's $1.9 trillion coronavirus relief package is expected to pass the House Friday, but the final version of the legislation won't include a provision raising the federal minimum wage to $15 an hour. The Senate's parliamentarian ruled senators cannot vote on the bill with the minimum wage increase in it using the simple-majority reconciliation process. Democratic Michigan Congresswoman Haley Stevens joined CBSN to discuss the relief bill and the proposed wage hike.
FDA panel OKs Johnson & Johnson COVID-19 vaccine
An FDA advisory panel voted Friday in favor of Johnson & Johnson's coronavirus vaccine. If the FDA gives the final approval, millions of doses could ship out as early as this weekend. The news comes as the CDC warns declines in cases and hospitalizations may be stalling. Dr. Dara Kass, and ER doctor and medical contributor for Yahoo News, joins CBSN to discuss the latest in the fight against COVID-19.
Some miss second dose of COVID vaccine
A new report by CBS MoneyWatch found an increasing number of people are not getting their second COVID-19 vaccine shot when they're supposed to. CBSN's Tanya Rivera spoke with MoneyWatch senior report Stephen Gandel about what this means for the nation's vaccination efforts.
Queen Elizabeth encourages COVID vaccinations
Britain's Queen Elizabeth is encouraging people to get vaccinated against the coronavirus to help protect others. She took part in a Zoom conference with doctors and said the shot "didn't hurt at all." CBS News' Ian Lee reports from London.
Study: Pfizer vaccine reduces transmission
A new U.K. study found the Pfizer coronavirus vaccine reduced transmission after just one dose. Dr. Bob Lahita joins CBSN to discuss the findings, as well as the possible need for booster shots against new variants, a new CBS News poll on attitudes about vaccination, and the process of reopening schools amid the pandemic.
"A Shot of Hope": Mistrust and access
Communities of color have a long history of mistrust in the medical community that's grounded in a history of abuses like the U.S. Public Health Service syphilis study in Tuskegee, Alabama, and the case of Henrietta Lacks. But they also suffer from a lack of access. CBSN speaks to family members connected to those cases, as well as doctors and community leaders overcoming roadblocks to get the vaccine to those who need it most. Plus, Montana Governor Greg Gianforte explains his state's success in COVID-19 vaccinations. Montana has one of the best vaccination rates in the country.
"A Shot of Hope": Getting the vaccine
Millions of Americans have received doses of the coronavirus vaccines so far. On Thursday, President Biden marked 50 million shots given since he took office. This is a significant milestone, but access remains an issue. Acting FEMA director Bob Fenton explains how his agency is trying to ramp up the rollout of the vaccine. Plus, Dr. Anthony Fauci explains if the new Johnson & Johnson vaccine will be effective against a new variant found in New York City.
50 million COVID shots administered since Biden inauguration
The Biden administration is marking a new milestone in the fight against the coronavirus pandemic. The U.S. has administered 50 million of its promised 100 million vaccine doses in just five weeks. This comes as homegrown variants cause alarm on both coasts on the country. Dr. Richard Besser, the president and CEO of the Robert Wood Johnson Foundation and the former acting director of the CDC, joins CBSN to discuss the latest.
Minimum wage and COVID-19 relief package
The Senate is weighing a way forward for a COVID-19 relief package as President Biden makes his pitch to Republican governors to support his plan. Franco Ordoñez, a White House correspondent for NPR, and Liz Goodwin, deputy Washington bureau chief of The Boston Globe, join CBSN's "Red & Blue" anchor Elaine Quijano to discuss the latest on that plus other headlines out of Washington.
Doctor on different COVID vaccine options
The FDA could issue emergency approval of Johnson and Johnson's single-dose COVID-19 vaccine as soon as Friday. Meanwhile there's growing evidence of the effectiveness of Pfizer's vaccine in the real world. Dr. Leo Nissola joins CBSN with more on the differences between the single and multi-dose vaccines and efforts to convince uncertain Americans to take them.
Vaccine maker races to combat new variant
AstraZeneca will try for emergency approval of its vaccine in the U.S. after scientists found this version of the vaccine has been effective against the U.K. variant. Charlie D'Agata reports.
Fighting the COVID-19 variants
Moderna is seeking approval for an updated vaccine aimed at fighting the COVID-19 variant first found in South Africa. It means people who are vaccinated twice might need a third shot, and possibly more in the future. David Begnaud reports.
Live
U.S. reducing troop footprint in Middle East, sources say
Son of Stephen Hubbard, American freed from Russian jail, speaks out
Witkoff blasted for calling Putin a "humanitarian"
Supreme Court rejects bid to restrict treatments for trans inmates
Judge curbs DHS efforts to conduct sweeps for possible noncitizen voters
Investigation
We tested an experimental weight loss drug. The results were "terrifying."
U.S. ordering some government staff to depart Saudi Arabia
Investigation
Armed federal agents knock on doors looking for noncitizen voters
